Induced pluripotent stem cells model personalized variations in liver disease resulting from α1‐antitrypsin deficiency

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|1|147-157

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.1, 2015-07, pp. : 147-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alpha‐1‐antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 198-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential of human induced pluripotent stem cells in studies of liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 303-311

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation

By  

THE JOURNAL OF PATHOLOGY, Vol. 237, Iss. 1, 2015-09 ,pp. : 98-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Echocardiographic evaluation in subjects with α1‐Antitrypsin deficiency

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 9, 2015-09 ,pp. : 949-954

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhanced Chondrogenesis of Induced Pluripotent Stem Cells From Patients With Neonatal‐Onset Multisystem Inflammatory Disease Occurs via the Caspase 1–Independent cAMP/Protein Kinase A/CREB Pathway

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 1, 2015-01 ,pp. : 302-314

John Wiley & Sons Inc

Access to resources Recommend Favorite